Prescription medicines


Product information:

RELENZA product monograph

Health-care Professional Information:

November 3, 2009 - Notice to Hospitals - Health Canada Endorsed Important Safety Information on PrRELENZA (zanamivir) Dry Powder for Inhalation

Consumer Information:

“Please read the “Consumer Information” leaflet for RELENZA located on this website as it contains important safety information on RELENZA.”


Trademarks are owned by or licensed to the GSK group of companies.